Phil Taylor
- Feature
Securing the supply chain
Terrorism, piracy and theft are becoming increasingly serious problems for chemistry companies. Phil Taylor finds out how they're protecting themselves
- News
Biosuccinic acid ready for take off?
With oil prices rising, the chemical industry is looking for alternative feedstocks, could biosuccinc acid be the answer?
- News
Screw tightens on pay-for-delay drug deals
Pharma's delaying tactics for generic drug market entry come under closer scrutiny on both sides of the Atlantic
- News
Pharma group aims to banish contaminated ingredients
Consortium aims to tighten pharmaceutical supply chain security and avoid drug contamination scandals
- News
New treatment hope for lupus patients
Positive results from two late stage trials offer hope for sufferers of the autoimmune disease lupus
- News
Tracing amyloid in Alzheimer's
Diagnostic compound allows researchers to look into the brains of Alzheimer's patients to gauge the effects of an experimental therapy
- News
New drug turns Alzheimer's theory on its head
An antihistamine that improves Alzheimer's symptoms has raised questions about our understanding of the disease
- News
GSK and Pfizer join forces in fight against HIV
Unique HIV joint venture formed by two pharma heavyweights
- News
Wyeth tunes up its discovery engine
US-based Wyeth has become the latest of the large pharmaceutical companies to tighten the focus of its early stage drug research